Synchronizing Blastocyst in Frozen Embryo Transfer

June 25, 2019 updated by: Yasmin Magdi, Al-Yasmeen Fertility and Gynecology Center

Synchronizing Blastocyst at Hatching Stage in Frozen Embryo Transfer Cycles

The aim of the present study is to determine if implantation rate could be increased in women undergoing frozen embryo transfer cycles in case of adjusting their embryo development at hatching stage.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

742

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Banhā, Egypt
        • Al-Yasmeen fertility and gynecology center
      • Cairo, Egypt
        • Ganna Fertility and Gynecology Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 33 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. Patients who will agree to participate and assign an informed consent form
  2. Only blastocyst transfer FET cycles
  3. Patients undergoing FET after their 1st IVF or ICSI cycle with no pregnancy at the fresh transfer
  4. Freeze-all cycles due to OHSS
  5. Freeze-all cycles due to poor endometrium
  6. Age 19-33 at the time of randomization.
  7. Their frozen blastocysts are 3 or less grade of expansion.
  8. Female with a ≥12 AFCs
  9. Endometrial thickness ≥ 8mm at the time of ovulation
  10. Women with their male partners will give only fresh semen
  11. Women who have no uterine abnormality by ultrasound
  12. BMI ≤ 31

Exclusion Criteria:

  1. Cycles undergoing preimplantation genetic diagnosis.
  2. Women who have previous two cycles of implantation failure at fresh transfer
  3. Women who have previous two FET failed cycles
  4. Any uterine pathology (myomas, adenomyosis, endocrinopathies, thrombophilia, chronic pathologies, acquired or congenital uterine abnormalities)
  5. Patients with severe endometriosis
  6. Presence of uni- or bilateral hydrosalpinx
  7. Recurrent pregnancy loss.
  8. Any medical condition that affect fertility.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: frozen/thawed
blastocysts with three or less grade of expansion will be thawed and then subsequently transferred into women uterus three hours post-thawing.
Experimental: synchronized frozen/thawed hatching blastocysts
blastocyst thawing (with three or less grade of expansion) will take place the day before embryo transfer in order to reach hatching stage
transferring frozen/thawed a synchronized blastocysts at hatching stage into female uterus.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ongoing implantation rate
Time Frame: 12 weeks
ultrasound detection of ongoing gestational sacs with heartbeats after 12 weeks of gestation per transferred embryos
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 21, 2017

Primary Completion (Actual)

January 15, 2018

Study Completion (Actual)

May 10, 2018

Study Registration Dates

First Submitted

April 21, 2017

First Submitted That Met QC Criteria

April 21, 2017

First Posted (Actual)

April 25, 2017

Study Record Updates

Last Update Posted (Actual)

June 27, 2019

Last Update Submitted That Met QC Criteria

June 25, 2019

Last Verified

June 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 001-2017

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Embryo Implantation

Clinical Trials on synchronizing blastocysts

Subscribe